Gaudium IVF Reports Rs 55.97 Crore Unutilized IPO Proceeds

Rs 34.03 crore of Rs 90.00 crore IPO funds utilized by June 30, 2026.
Reader Takeaway: Deployment timeline shifted, but end-use objectives remain unchanged.

What just happened

Infomerics Valuation and Rating Limited, the monitoring agency, has released its report on Gaudium IVF and Women Health Limited's Initial Public Offering (IPO) proceeds for the quarter ending June 30, 2026. The report indicates that out of the total Rs 90.00 crore raised, only Rs 34.03 crore had been utilized by the said date, leaving Rs 55.97 crore unutilized.

Why this matters

Investors who participated in the IPO are keen to see the company deploy capital effectively for its expansion plans. The report provides transparency on how the raised funds are being used and highlights any deviations from the original plan. While the overall objectives remain the same, the delay in deploying funds for new IVF centers could impact the company's growth trajectory in the short term.

The backstory

Gaudium IVF and Women Health Limited raised Rs 90.00 crore through its IPO. The funds were earmarked for specific purposes including funding new IVF centers, repayment of borrowings, general corporate purposes, and issue expenses. The company's IPO listing was on February 27, 2026.

What changes now

The primary change highlighted is the deferment of the deployment schedule for funding new IVF centers. The expenditure initially planned for FY2025-26 is now expected to occur in FY2026-27, attributed to the limited time between listing and the financial year-end. Approximately Rs 5.76 crore from General Corporate Purpose funds was used for the 'Gaudium Women Hospital' in Lucknow.

Risks to watch

While the monitoring agency found no material deviation in the end-use objectives, any further significant delays in deploying the unutilized funds for expansion could pose a risk to the company's growth and investor returns. The effective management of the Lucknow hospital project will also be crucial.

Peer comparison

(No specific peer comparison data available in the filing)

Context metrics (time-bound)

• Total IPO Proceeds: Rs 90.00 crore
• Utilized by June 30, 2026: Rs 34.03 crore
• Unutilized by June 30, 2026: Rs 55.97 crore
• Deployment for New IVF Centers: Rs 1.03 crore utilized out of Rs 50.00 crore planned.
• Repayment of Borrowings: Rs 18.07 crore utilized out of Rs 20.00 crore planned.
• General Corporate Purpose: Rs 7.21 crore utilized out of Rs 12.28 crore planned.
• Issue Expenses: Rs 7.72 crore utilized out of Rs 7.72 crore planned.

What to track next

Investors should track the actual deployment of the remaining Rs 55.97 crore in the current fiscal year, particularly the progress in establishing new IVF centers and the performance of the Lucknow hospital project.